These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25553437)

  • 21. Anticancer Natural Coumarins as Lead Compounds for the Discovery of New Drugs.
    Pinto DCGA; Silva AMS
    Curr Top Med Chem; 2017; 17(29):3190-3198. PubMed ID: 29243581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases.
    Valente S; Bana E; Viry E; Bagrel D; Kirsch G
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5827-30. PubMed ID: 20800482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
    Thakur A; Singla R; Jaitak V
    Eur J Med Chem; 2015 Aug; 101():476-95. PubMed ID: 26188907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents.
    Rubab L; Afroz S; Ahmad S; Hussain S; Nawaz I; Irfan A; Batool F; Kotwica-Mojzych K; Mojzych M
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives.
    Kasperkiewicz K; Ponczek MB; Owczarek J; Guga P; Budzisz E
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32213944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coumarin derivatives: an updated patent review (2012-2014).
    Katsori AM; Hadjipavlou-Litina D
    Expert Opin Ther Pat; 2014 Dec; 24(12):1323-47. PubMed ID: 25327901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells.
    Saidu NE; Valente S; Bana E; Kirsch G; Bagrel D; Montenarh M
    Bioorg Med Chem; 2012 Feb; 20(4):1584-93. PubMed ID: 22264758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration of 3,4-unsubstituted coumarins as thioredoxin reductase 1 inhibitors for cancer therapy.
    Nikitjuka A; Ozola M; Jackevica L; Bobrovs R; Žalubovskis R
    Org Biomol Chem; 2023 Dec; 21(48):9630-9639. PubMed ID: 38018884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coumarin Compounds in Medicinal Chemistry: Some Important Examples from the Last Years.
    Pereira TM; Franco DP; Vitorio F; Kummerle AE
    Curr Top Med Chem; 2018; 18(2):124-148. PubMed ID: 29595110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview.
    Ratre P; Kulkarni S; Das S; Liang C; Mishra PK; Thareja S
    Med Oncol; 2022 Dec; 40(1):41. PubMed ID: 36471176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents.
    Kulkarni MV; Kulkarni GM; Lin CH; Sun CM
    Curr Med Chem; 2006; 13(23):2795-818. PubMed ID: 17073630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationship studies of 4-methylcoumarin derivatives as anticancer agents.
    Miri R; Nejati M; Saso L; Khakdan F; Parshad B; Mathur D; Parmar VS; Bracke ME; Prasad AK; Sharma SK; Firuzi O
    Pharm Biol; 2016; 54(1):105-10. PubMed ID: 26017566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybrids of Coumarin Derivatives as Potent and Multifunctional Bioactive Agents: A Review.
    Fotopoulos I; Hadjipavlou-Litina D
    Med Chem; 2020; 16(3):272-306. PubMed ID: 31038071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural products and their derivatives as cyclooxygenase-2 inhibitors.
    Chandel P; Rawal RK; Kaur R
    Future Med Chem; 2018 Oct; 10(20):2471-2492. PubMed ID: 30325206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Journey and Recent Advances in the Synthesis of Coumarin Derivatives.
    Sinha S; Singh K; Ved A; Hasan SM; Mujeeb S
    Mini Rev Med Chem; 2022; 22(9):1314-1330. PubMed ID: 34784861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer.
    Venkata Sairam K; Gurupadayya BM; Chandan RS; Nagesha DK; Vishwanathan B
    Curr Drug Deliv; 2016; 13(2):186-201. PubMed ID: 26135671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
    Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
    Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel osthole derivatives as potential anti-breast cancer treatment.
    You L; An R; Wang X; Li Y
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7426-8. PubMed ID: 21051232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC; Liu ZP
    Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.